3694 -- Reward Work Act | Poliscope

Reward Work Act

3694

118th Congress

Finance and Financial Sector

In Committee

Reward Work Act

Legislative Progress

✓

Introduced

Committee

Floor Vote

Other Chamber

Enacted

Introduced

May 25, 2023

Latest Action

May 25, 2023

Primary Sponsor

Jesús G. "Chuy" GarcíaDemocratic(IL)

Momentum (last 30 days)

score

0 actions · 0 new cosponsors · 0 votes

Speed vs cohort

0pct

0d open

vs 10,564 other HR bills in the 118th — cohort avg 68d

Summary

Reward Work Act This bill prohibits issuers from purchasing their own securities on a national exchange. The bill also requires one-third of an issuer's board of directors to be elected by employees in order for the issuer to be allowed to register securities.

Lobbying filings that explicitly cite this bill (1)

These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.

Filing registrants (1)

DAVE KOLBE CONSULTING (1)

PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATIONclient→DAVE KOLBE CONSULTING

2023 · second_quarter · Pharmacy

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

H.R. 830 HELP COPAYS ACT - Urging support of the Help Copays Act to ensure affordable access to life-saving medications for all Americans. Provide relief to patients by capping copayments for prescription drugs. S. 1246 SMART PRICES ACT - Urging opposition to the SMART legislation. The emphasis on price controls for prescription drug price negotiations would have adverse effects on future research, investments, and empllyment opportunites in our country. H.R. 3694 WTO'S Expansion of TRIPS Waivers for Drugs - Urging opposition of the waiver to COVID-19 diagnostic devices and treatments, as many WTO members are proposing, would endanger American jobs without improving global health.

Client expense: Not reported · Firm income: $30,000